Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Aqupla (nedaplatin)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(6)
News
Trials
Company:
Simcere
Drug class:
DNA synthesis inhibitor
Related drugs:
‹
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
temozolomide gel (7)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
hydroxyurea (3)
mercaptopurine (3)
thiotepa (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine-releasing intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
PCS3117 (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PTX-200 (0)
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
temozolomide gel (7)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
hydroxyurea (3)
mercaptopurine (3)
thiotepa (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine-releasing intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
PCS3117 (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PTX-200 (0)
›
Associations
(6)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
nedaplatin
Sensitive: A2 - Guideline
nedaplatin
Sensitive
:
A2
nedaplatin
Sensitive: A2 - Guideline
nedaplatin
Sensitive
:
A2
HER-2 negative
HER2 Negative Breast Cancer
HER-2 negative
HER2 Negative Breast Cancer
nedaplatin
Sensitive: C3 – Early Trials
nedaplatin
Sensitive
:
C3
nedaplatin
Sensitive: C3 – Early Trials
nedaplatin
Sensitive
:
C3
BRCA2 mutation
Ovarian Cancer
BRCA2 mutation
Ovarian Cancer
nedaplatin
Resistant: C3 – Early Trials
nedaplatin
Resistant
:
C3
nedaplatin
Resistant: C3 – Early Trials
nedaplatin
Resistant
:
C3
BRCA1 mutation
Ovarian Cancer
BRCA1 mutation
Ovarian Cancer
nedaplatin
Resistant: C3 – Early Trials
nedaplatin
Resistant
:
C3
nedaplatin
Resistant: C3 – Early Trials
nedaplatin
Resistant
:
C3
FOXP3 overexpression
Esophageal Squamous Cell Carcinoma
FOXP3 overexpression
Esophageal Squamous Cell Carcinoma
nedaplatin
Sensitive: C3 – Early Trials
nedaplatin
Sensitive
:
C3
nedaplatin
Sensitive: C3 – Early Trials
nedaplatin
Sensitive
:
C3
SLFN11 expression
Acute Lymphocytic Leukemia
SLFN11 expression
Acute Lymphocytic Leukemia
nedaplatin
Sensitive: D – Preclinical
nedaplatin
Sensitive
:
D
nedaplatin
Sensitive: D – Preclinical
nedaplatin
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login